NCT06934395

Brief Summary

The goal of PROJECT SUSTAIN is to optimize Healthy Choices to advance an adaptive and scalable intervention designed to improve self-management of alcohol and HIV in Young People with HIV (YPWH) while understanding the context for state-wide implementation and sustainment in a Hybrid Experimental Design (HED). SUSTAIN utilizes mHealth and telehealth intervention delivery of Healthy Choices (HC), combined with text messaging between sessions, to increase the likelihood of daily medication adherence (primary outcome), and increase the likelihood of achieving viral suppression and meeting criteria for no risky alcohol use at month 3 (secondary outcome).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P25-P50 for not_applicable hiv

Timeline
3mo left

Started Mar 2025

Shorter than P25 for not_applicable hiv

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Mar 2025Jul 2026

Study Start

First participant enrolled

March 22, 2025

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

April 11, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 18, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Last Updated

June 19, 2025

Status Verified

June 1, 2025

Enrollment Period

1.4 years

First QC Date

April 11, 2025

Last Update Submit

June 18, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • ART Adherence

    Antiretroviral (ART) adherence will be assessed daily using an Ecological Momentary Assessment (EMA) survey delivered via SMS. Individuals will be asked whether they took some or all of their medication.

    Daily for 56 Days

Secondary Outcomes (2)

  • Alcohol Use

    Baseline, 3 month, and 6 month

  • HIV Viral Load

    Baseline, 3 month, and 6 month

Study Arms (4)

Within-participant micro-randomization - Prompt

EXPERIMENTAL

Participants will be randomized daily to receive a text messaged prompt focused on medication adherence or stress.

Behavioral: Text Message Prompts

Within-participant micro-randomization - No Prompt

NO INTERVENTION

Participants will be randomized daily to not receive a text messaged prompt focused on medication adherence or stress.

Between-participant randomization - CIAS + Week 2 Coaching Session

EXPERIMENTAL

Participants will be randomized at the end of week 2 (day 14) to receive the Healthy Choices telehealth intervention with trained interventionist at week 2. All enrolled participants will receive an initial Healthy Choices mHealth intervention which involves a MI based coaching session via Computerized Intervention Authoring Software (CIAS).

Behavioral: Healthy Choices

Between-participant randomization - CIAS + No Week 2 Coaching Session

NO INTERVENTION

Participants will be randomized at the end of week 2 (day 14) to NOT receive the Healthy Choices telehealth intervention with trained interventionist at week 2. All enrolled participants will receive an initial Healthy Choices mHealth intervention which involves a MI based coaching session via Computerized Intervention Authoring Software (CIAS).

Interventions

Healthy ChoicesBEHAVIORAL

Healthy Choices is an adapted and developmentally tailored intervention designed to address self-management of risk behaviors and HIV from Motivational Enhancement Therapy, a brief alcohol intervention in SAMHSA's registry of evidenced-based programs. For the purposes of this project, this intervention will be delivered as a combination approach, with all participants receiving an initial session via CIAS, and randomized to either receiving a telehealth session with a trained interventionist at week 2, with additional randomizations for telehealth sessions at weeks 4 and 6. The goal is to test if delivering (vs. not delivering) a coaching session increases the likelihood of achieving viral suppression and meeting criteria for no risky alcohol use at month 3

Between-participant randomization - CIAS + Week 2 Coaching Session

This within-participant micro-randomization will test whether, on average, delivering (vs. not delivering) a text messaged prompt focused on medication adherence or stress increases the likelihood of medication adherence by the end of the current day .

Within-participant micro-randomization - Prompt

Eligibility Criteria

Age18 Years - 29 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Be 18 years and 0 months to 29 years and 11 months.
  • Currently reside in Florida
  • History of alcohol use
  • Are not pregnant nor trying to conceive within the study's timeline
  • Are able to read and understand English
  • Have internet access via smartphone, tablet or computer
  • Are willing to provide informed consent.

You may not qualify if:

  • Adults unable to consent
  • Prisoners
  • Those using long-acting injectables as HIV medication regimen

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Florida State University, Center for Translational Behavioral Science

Tallahassee, Florida, 32310, United States

RECRUITING

University of South Florida

Tampa, Florida, 33620, United States

ACTIVE NOT RECRUITING

Northeastern University

Boston, Massachusetts, 02115, United States

ACTIVE NOT RECRUITING

University of Michigan

Ann Arbor, Michigan, 48106, United States

ACTIVE NOT RECRUITING

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Central Study Contacts

Karen MacDonell, PhD

CONTACT

Sara Green, MSW

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 11, 2025

First Posted

April 18, 2025

Study Start

March 22, 2025

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

June 19, 2025

Record last verified: 2025-06

Locations